|
[1]
|
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会. 中国心房颤动管理指南(2025) [J]. 中华心律失常学杂志, 2025, 29(4): 265-338.
|
|
[2]
|
王显. 从风论治冠心病的临床实践与思考[J]. 中医学报, 2025, 40(9): 1809-1816.
|
|
[3]
|
杜宜航, 柴若宁, 段城林, 等. 基于“火郁发之”理论探讨宣郁清热法在房颤治疗中的应用[J]. 中国中医基础医学杂志, 2025, 31(4): 707-709.
|
|
[4]
|
万泳宏, 刘建和. 从“阴火-宗气”不两立探讨心房颤动的中医机理和证治[J]. 云南中医中药杂志, 2025, 46(6): 30-33.
|
|
[5]
|
谭玉培, 李明轩, 刘红旭, 等. 从“肺火痰实”探析阵发性房颤的治疗[J]. 中华中医药杂志, 2024, 39(12): 6508-6511.
|
|
[6]
|
丁宇坤, 李思聪, 王显. 《血证论》辨治心房颤动的思想探讨[J]. 中国中医急症, 2024, 33(12): 2206-2208+2215.
|
|
[7]
|
唐荣辰, 宫丽鸿. 心房颤动的中医药治疗研究进展[J]. 中国中医急症, 2024, 33(4): 739-741+749.
|
|
[8]
|
张惠琴. 对319例非瓣膜性心房颤动的中医证候及电解质、甲状腺功能和血脂情况的分析[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2023.
|
|
[9]
|
Bunnell, D.J. (2025) Atrial Fibrillation. Physician Assistant Clinics, 10, 287-296. https://doi.org/10.1016/j.cpha.2024.11.005
|
|
[10]
|
王健, 戴婷, 蒋国军, 等. 骨保护蛋白/核因子-κβ受体活化因子/核因子-κβ受体活化因子配体轴与心脏瓣膜病合并持续性心房颤动患者改良迷宫术后心房颤动复发的关系及其作用机制研究[J]. 实用心脑肺血管病杂志, 2020, 28(10): 32-36.
|
|
[11]
|
McDermott, L.L., Bohorquez, J., Zaatari, G., et al. (2023) Atrial ECG Dynamics in Atrial Fibrillation. Journal of the American College of Cardiology, 81, 195. https://doi.org/10.1016/s0735-1097(23)00639-3
|
|
[12]
|
Matsunaga-Lee, Y., Egami, Y., Sugino, A., Kobayashi, N., Abe, M., Nohara, H., et al. (2026) Hemoglobin Levels as a Marker of Arrhythmia Recurrence after Atrial Fibrillation Ablation. Journal of Arrhythmia, 42, e70473. https://doi.org/10.1002/joa3.70473
|
|
[13]
|
Luther, V. and Katritsis, G. (2020) Ablation of Atrial Fibrillation and Atrial Tachycardia. In: Decoding Cardiac Electrophysiology, Springer, 73-86. https://doi.org/10.1007/978-3-030-28672-9_6
|
|
[14]
|
姜兆磊, 曾千龙, 林政宇, 等. 梅氏微创心房颤动消融术治疗心房颤动合并射血分数降低型心力衰竭或射血分数轻度降低型心力衰竭的效果评价[J]. 中国心血管病研究, 2025, 23(4): 293-297.
|
|
[15]
|
Puwatnuttasit, P., Chulalaksananukul, R., Sinphurmsukskul, S. and Satitthummanid, S. (2025) Impact of Atrial Fibrillation on Atrial Function in HFpEF. Journal of the American College of Cardiology, 85, 1707. https://doi.org/10.1016/s0735-1097(25)02191-6
|
|
[16]
|
Ren, M., Yao, Y., Yue, X., Ning, Y. and Yang, Y. (2021) Atrial Cardiomyopathy and Atrial Fibrillation in Cancer. Cardiology Research and Practice, 2021, 1-7. https://doi.org/10.1155/2021/6685953
|
|
[17]
|
Petramala, L., Carnevale, R., Marino, L., D’Ambrosio, L., Bartimoccia, S., D’Amico, E.A., et al. (2026) Thrombaxane-b2 as a Predictor Marker of Atrial Fibrillation. International Journal of Cardiology Cardiovascular Risk and Prevention, 29, 200604. https://doi.org/10.1016/j.ijcrp.2026.200604
|
|
[18]
|
刘萍, 杜玲玲. 除颤复脉方联合缬沙坦对非瓣膜性阵发性心房颤动患者经胺碘酮复律后窦性心律维持及左心房重构和心功能的影响[J]. 现代中西医结合杂志, 2021, 30(22): 2469-2472.
|
|
[19]
|
史亚绘, 石花. 探讨替米沙坦在心房颤动上游治疗中的临床疗效及对患者心房颤动复发率的影响[J]. 中国临床医生杂志, 2021, 49(11): 1304-1307.
|